Logo image of NVTS

NAVITAS SEMICONDUCTOR CORP (NVTS) Stock Fundamental Analysis

USA - NASDAQ:NVTS - US63942X1063 - Common Stock

8.44 USD
+0.44 (+5.5%)
Last: 10/10/2025, 2:51:06 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NVTS. NVTS was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. While NVTS seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, NVTS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year NVTS has reported negative net income.
In the past year NVTS has reported a negative cash flow from operations.
NVTS had negative earnings in 4 of the past 5 years.
NVTS had a negative operating cash flow in each of the past 5 years.
NVTS Yearly Net Income VS EBIT VS OCF VS FCFNVTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -27.70%, NVTS is doing worse than 84.82% of the companies in the same industry.
NVTS has a worse Return On Equity (-32.01%) than 78.57% of its industry peers.
Industry RankSector Rank
ROA -27.7%
ROE -32.01%
ROIC N/A
ROA(3y)-11.42%
ROA(5y)-25.04%
ROE(3y)-14.37%
ROE(5y)-65.51%
ROIC(3y)N/A
ROIC(5y)N/A
NVTS Yearly ROA, ROE, ROICNVTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

NVTS has a Gross Margin of 27.09%. This is in the lower half of the industry: NVTS underperforms 75.00% of its industry peers.
NVTS's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for NVTS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.92%
GM growth 5Y2.03%
NVTS Yearly Profit, Operating, Gross MarginsNVTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

6

2. Health

2.1 Basic Checks

NVTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
NVTS has more shares outstanding than it did 1 year ago.
NVTS has more shares outstanding than it did 5 years ago.
NVTS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NVTS Yearly Shares OutstandingNVTS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
NVTS Yearly Total Debt VS Total AssetsNVTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

NVTS has an Altman-Z score of 15.29. This indicates that NVTS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of NVTS (15.29) is better than 79.46% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that NVTS is not too dependend on debt financing.
NVTS's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. NVTS outperforms 70.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 15.29
ROIC/WACCN/A
WACC11.66%
NVTS Yearly LT Debt VS Equity VS FCFNVTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 8.23 indicates that NVTS has no problem at all paying its short term obligations.
The Current ratio of NVTS (8.23) is better than 91.07% of its industry peers.
A Quick Ratio of 7.59 indicates that NVTS has no problem at all paying its short term obligations.
NVTS has a better Quick ratio (7.59) than 90.18% of its industry peers.
Industry RankSector Rank
Current Ratio 8.23
Quick Ratio 7.59
NVTS Yearly Current Assets VS Current LiabilitesNVTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

The earnings per share for NVTS have decreased by -9.52% in the last year.
Looking at the last year, NVTS shows a very negative growth in Revenue. The Revenue has decreased by -25.65% in the last year.
NVTS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 118.05% yearly.
EPS 1Y (TTM)-9.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
Revenue 1Y (TTM)-25.65%
Revenue growth 3Y51.96%
Revenue growth 5Y118.05%
Sales Q2Q%-29.21%

3.2 Future

The Earnings Per Share is expected to grow by 21.84% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 18.25% on average over the next years. This is quite good.
EPS Next Y13.87%
EPS Next 2Y12.58%
EPS Next 3Y14.53%
EPS Next 5Y21.84%
Revenue Next Year-42.35%
Revenue Next 2Y-20.99%
Revenue Next 3Y4.01%
Revenue Next 5Y18.25%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NVTS Yearly Revenue VS EstimatesNVTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
NVTS Yearly EPS VS EstimatesNVTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.2 -0.4 -0.6

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NVTS. In the last year negative earnings were reported.
Also next year NVTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NVTS Price Earnings VS Forward Price EarningsNVTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NVTS Per share dataNVTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

NVTS's earnings are expected to grow with 14.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.58%
EPS Next 3Y14.53%

0

5. Dividend

5.1 Amount

NVTS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NAVITAS SEMICONDUCTOR CORP

NASDAQ:NVTS (10/10/2025, 2:51:06 PM)

8.44

+0.44 (+5.5%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners39.68%
Inst Owner Change0%
Ins Owners2.94%
Ins Owner Change36.99%
Market Cap1.80B
Analysts73.33
Price Target6.87 (-18.6%)
Short Float %28.3%
Short Ratio2.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.51%
Min EPS beat(2)-0.95%
Max EPS beat(2)5.97%
EPS beat(4)3
Avg EPS beat(4)3.82%
Min EPS beat(4)-0.95%
Max EPS beat(4)5.97%
EPS beat(8)5
Avg EPS beat(8)4.94%
EPS beat(12)9
Avg EPS beat(12)9.42%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.49%
Min Revenue beat(2)-1.79%
Max Revenue beat(2)-1.19%
Revenue beat(4)0
Avg Revenue beat(4)-3.36%
Min Revenue beat(4)-7.36%
Max Revenue beat(4)-1.19%
Revenue beat(8)3
Avg Revenue beat(8)-1.38%
Revenue beat(12)7
Avg Revenue beat(12)0.4%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)56.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.65%
EPS NY rev (1m)-1.06%
EPS NY rev (3m)-13.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-36.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-23.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 26.39
P/FCF N/A
P/OCF N/A
P/B 4.63
P/tB 11.04
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0.32
BVpS1.82
TBVpS0.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.7%
ROE -32.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.09%
FCFM N/A
ROA(3y)-11.42%
ROA(5y)-25.04%
ROE(3y)-14.37%
ROE(5y)-65.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.92%
GM growth 5Y2.03%
F-Score2
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8.4%
Cap/Sales 2.72%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.23
Quick Ratio 7.59
Altman-Z 15.29
F-Score2
WACC11.66%
ROIC/WACCN/A
Cap/Depr(3y)37.63%
Cap/Depr(5y)103.58%
Cap/Sales(3y)8.79%
Cap/Sales(5y)7.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
EPS Next Y13.87%
EPS Next 2Y12.58%
EPS Next 3Y14.53%
EPS Next 5Y21.84%
Revenue 1Y (TTM)-25.65%
Revenue growth 3Y51.96%
Revenue growth 5Y118.05%
Sales Q2Q%-29.21%
Revenue Next Year-42.35%
Revenue Next 2Y-20.99%
Revenue Next 3Y4.01%
Revenue Next 5Y18.25%
EBIT growth 1Y7.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year19.33%
EBIT Next 3Y18.59%
EBIT Next 5Y23.31%
FCF growth 1Y-6.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.37%
OCF growth 3YN/A
OCF growth 5YN/A